Abstract��OBJECTIVE To conduct an economic evaluation of Baofukang versus Langyi in the treatment of pregnancy with vulvovaginal candidiasis by means of cost-minimization analysis. Furthermore, provide reference for reasonable clinical prescription and decision-making. METHODS Meta-analysis was conducted to support the safety data and effectiveness data of pharmacoeconomic evaluation based on literature review; guidelines and clinical experts�� suggestion were used to find out treatment routes to calculate total direct medical costs. Cost-minimization analysis was conducted from the societal perspective. RESULTS The total direct medical costs of group Baofukang was lower than group Langyi��s. Sensitivity analysis indicated the results were robust. CONCLUSION In contrast with Langyi, Baofukang is a more economic therapy in the treatment of pregnancy with vulvovaginal candidiasis.
������,¬��,������. ������˨��������������ϲ�����������˿��ĸ��������С�ɱ�����[J]. �й�ҩѧ��־, 2017, 52(13): 1183-1187.
DUAN Xiao-min, LU Yan, SUN Li-hua. Cost-Minimization Analysis of Baofukang Compared with Langyi in the Treatment of Pregnancy with Vulvovaginal Candidiasis. Chinese Pharmaceutical Journal, 2017, 52(13): 1183-1187.
WORKOWSKI K A, BOLAN G A. Sexually Transmitted Disease Treatment Guidelines 2015 . Mmov Morb Mortal Wkly Rep,2015, 64(3):1.
[2]
DONG Y. Diagnosis and treatment of recurrent candidiasis vaginitis . J Pract Obstet Gynecol(ʵ�ø�������־), 2000, 16(4):175-176.
[3]
XIE X, GOU W L. Obstetrics and Gynecology(������ѧ) . Beijing: People��s Medical Publishing House, 2013: 249-250.
[4]
WANG P. A comparative study of nitrofurantoin parenteral vaginal soft capsule and Baobuxiang suppository in the treatment of vaginitis during pregnancy . Guide China Med(�й�ҽҩָ��),2013, 11(24):179-180.
[5]
ZHANG X Y. Clinical observation on the treatment of candidal candid carcinitis in pregnancy . J Med Theory Pract(ҽѧ������ʵ��), 2013, 26(12):1627-1628.
[6]
QIU X Y. Epidemiologic study and pathogenic candida species on pregnancy and vulvovaginal candidiasis . Tianjin:Tianjin Medical University, 2008.
[7]
XIE X, GOU W L. Obstetrics and Gynecology(������ѧ) . Beijing: People��s Medical Publishing House, 2013: 247-252.
[8]
SONG L,TANG K M. Analysis of the use of antifungal in the treatment of candidal vaginitis . Contem Med (����ҽѧ), 2010, 16(33):138-139.
[9]
ZHU Y. Prospective Multicenter Investigation of Epidemiological Characteristics of Preterm . Fudan University, 2012. CHEN J H. Application and evaluation of clinical nursing path in patients with puerperal infection . J North Sichuan Med Coll(����ҽѧԺѧ��),2008, 23(2): 184-186. LI B. Application of clinical nursing path in patients with puerperal infection . Aerosp Med(���պ���ҽѧ��־), 2012, 23(3): 350-352. WANG Y Q. Observation of clinical nursing path in patients with puerperal infection . Healthy People (��ҽ���), 2015, 9(12): 243-244. WANG L X. Application of clinical pathway in puerperal infection nursing. Chin J Mod Drug Appl(�й��ִ�ҩ��Ӧ��), 2015,9(17): 237-238. CHEN L. Application of clinical nursing path in patients with puerperal infection nursing . Mod Health(�ִ�����), 2015, 4(2): 202-203. WANG S J. Application of clinical nursing path in patients with puerperal infection nursing . Chin J Nosoco(�л�ҽԺ��Ⱦѧ��־),2013, 23(6): 1387-1388. JIANG J. Application of clinical nursing path in patients with puerperal infection nursing. Guide China Med(�й�ҽҩָ��), 2014, 23(13): 371-372. CHE Q M. Experience of clinical nursing care of 76 cases of patients with puerperal infection . Guide China Med(�й�ҽҩָ��),2014, 12(27): 331-332. YUAN W X, ZHONG P J, HU J Y. Correlation analysis of neonatal hospital infection and hospitalization expenses. J Nur Administ(���������־),2003,3(2): 40-42. WANG M D. Pediatrics(5th ed) (����ѧ). Beijing: People��s Medical Publishing House, 2000:243. TIAN X Y, SUN L H. Introduction to pharmacoeconomics research . China Pharm(�й�ҩҵ), 2004, 13(2):16-18. ZHANG C, ZHANG L L, CHEN L, et al. A systematic review of the pregnancy medication . Chin Pharm J(�й�ҩѧ��־), 2012, 47(11):858-862.